Attitudes toward syringe exchange programs in a rural Appalachian community

References

• Alpren C, Dawson EL, John B, Cranston K, Panneer N, Fukuda HD, Roosevelt K, Klevens RM, Bryant J, Peters PJ, et al. Opioid use fueling HIV transmission in an urban setting: an outbreak of HIV infection among people who inject drugs-Massachusetts, 2015-2018. Am J Public Health. 2020;110(1):37–44. doi:10.2105/AJPH.2019.305366.
   PubMed Web of Science ®Google Scholar
• Golden MR, Lechtenberg R, Glick SN, Dombrowski J, Duchin J, Reuer JR, Dhanireddy S, Neme S, Buskin SE. Outbreak of human immunodeficiency virus infection among heterosexual persons who are living homeless and inject drugs - Seattle, Washington, 2018. MMWR Morb Mortal Wkly Rep. 2019;68(15):344–9. doi:10.15585/mmwr.mm6815a2.
   PubMed Web of Science ®Google Scholar
• Peters PJ, Pontones P, Hoover KW, Patel MR, Galang RR, Shields J, Blosser SJ, Spiller MW, Combs B, Switzer WM, et al. HIV infection linked to injection use of oxymorphone in Indiana, 2014-2015. N Engl J Med. 2016;375(3):229–39. doi:10.1056/NEJMoa1515195.
   PubMed Web of Science ®Google Scholar
• Zibbell JE, Asher AK, Patel RC, Kupronis B, Iqbal K, Ward JW, Holtzman D. Increases in acute hepatitis C virus infection related to a growing opioid epidemic and associated injection drug use, United States, 2004 to 2014. Am J Public Health. 2018;108(2):175–81. doi:10.2105/AJPH.2017.304132.
   PubMed Web of Science ®Google Scholar
• Wurcel AG, Anderson JE, Chui KKH, Skinner S, Knox TA, Snydman DR, Stopka TJ. Increasing infectious endocarditis admissions among young people who inject drugs. Open Forum Infect Dis. 2016;3(3):ofw157. doi:10.1093/ofid/ofw157.
   PubMed Web of Science ®Google Scholar
• Deo SV, Raza S, Kalra A, Deo VS, Altarabsheh SE, Zia A, Khan MS, Markowitz AH, Sabik JF, Park SJ, et al. Admissions for infective endocarditis in intravenous drug users. J Am Coll Cardiol. 2018;71(14):1596–7. doi:10.1016/j.jacc.2018.02.011.
   PubMed Web of Science ®Google Scholar
• Fernandes RM, Cary M, Duarte G, Jesus G, Alarcão J, Torre C, Costa S, Costa J, Carneiro AV. Effectiveness of needle and syringe programmes in people who inject drugs - an overview of systematic reviews. BMC Public Health. 2017;17(1):309. doi:10.1186/s12889-017-4210-2.
   PubMed Web of Science ®Google Scholar
• Aspinall EJ, Nambiar D, Goldberg DJ, Hickman M, Weir A, Van Velzen E, Palmateer N, Doyle JS, Hellard ME, Hutchinson SJ, et al. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: a systematic review and meta-analysis. Int J Epidemiol. 2014;43(1):235–48. doi:10.1093/ije/dyt243.
   PubMed Web of Science ®Google Scholar
• Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, Jordan A, Degenhardt L, Hope V, Hutchinson S, et al. Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs. Cochrane Database Syst Rev. 2017;9(9):CD012021. doi:10.1002/14651858.CD012021.pub2.
   PubMed Web of Science ®Google Scholar
• Turner KME, Hutchinson S, Vickerman P, Hope V, Craine N, Palmateer N, May M, Taylor A, De Angelis D, Cameron S, et al. The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence. Addiction. 2011;106(11):1978–88. doi:10.1111/j.1360-0443.2011.03515.x.
   PubMed Web of Science ®Google Scholar
• Des Jarlais DC. Harm reduction in the USA: the research perspective and an archive to David Purchase. Harm Reduct J. 2017;14(1):51. doi:10.1186/s12954-017-0178-6.
   PubMed Web of Science ®Google Scholar
• Des Jarlais DC, McKnight C, Goldblatt C, Purchase D. Doing harm reduction better: syringe exchange in the United States. Addiction. 2009;104(9):1441–6. doi:10.1111/j.1360-0443.2008.02465.x.
   PubMed Web of Science ®Google Scholar
• Wejnert C, Hess KL, Hall HI, Van Handel M, Hayes D, Fulton P, An Q, Koenig LJ, Prejean J, Valleroy LA. Vital signs: trends in HIV diagnoses, risk behaviors, and prevention among persons who inject drugs - United States. MMWR Morb Mortal Wkly Rep. 2016;65(47):1336–42. doi:10.15585/mmwr.mm6547e1.
   PubMed Web of Science ®Google Scholar
• Lambdin BH, Bluthenthal RN, Wenger LD, Wheeler E, Garner B, Lakosky P, Kral AH. Overdose education and naloxone distribution within syringe service programs - United States, 2019. MMWR Morb Mortal Wkly Rep. 2020;69(33):1117–21. doi:10.15585/mmwr.mm6933a2.
   PubMed Web of Science ®Google Scholar
• Behrends CN, Nugent AV, Des Jarlais DC, Frimpong JA, Perlman DC, Schackman BR. Availability of HIV and HCV on-site testing and treatment at syringe service programs in the United States. J Acquir Immune Defic Syndr. 2018;79(2):e76–e78. doi:10.1097/QAI.0000000000001792.
   PubMed Web of Science ®Google Scholar
• Hagan H, McGough JP, Thiede H, Hopkins S, Duchin J, Alexander ER. Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. J Subst Abuse Treat. 2000;19(3):247–52. doi:10.1016/S0740-5472(00)00104-5.
   PubMed Web of Science ®Google Scholar
• Bluthenthal RN, Anderson R, Flynn NM, Kral AH. Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients. Drug Alcohol Depend. 2007;89(2-3):214–22. doi:10.1016/j.drugalcdep.2006.12.035.
   PubMed Web of Science ®Google Scholar
• Doherty MC, Junge B, Rathouz P, Garfein RS, Riley E, Vlahov D. The effect of a needle exchange program on numbers of discarded needles: a 2-year follow-up. Am J Public Health. 2000;90(6):936–9. doi:10.2105/ajph.90.6.936.
   PubMed Web of Science ®Google Scholar
• Levine H, Bartholomew TS, Rea-Wilson V, Onugha J, Arriola DJ, Cardenas G, Forrest DW, Kral AH, Metsch LR, Spencer E, et al. Syringe disposal among people who inject drugs before and after the implementation of a syringe services program. Drug Alcohol Depend. 2019;202:13–7. doi:10.1016/j.drugalcdep.2019.04.025.
   PubMed Web of Science ®Google Scholar
• Syringe Service Program Laws. The Policy Surveillance Program website. 2019 Aug. 1 [accessed 2020 Oct 11]. http://lawatlas.org/datasets/syringe-services-programs-laws.
   Google Scholar
• S.B. 1250. 55th Leg., Reg. Sess. (AZ 2021) [accessed 2021 Jun 30]. https://www.azleg.gov/legtext/55leg/1R/laws/0382.pdf.
   Google Scholar
• Fernández-Viña MH, Prood NE, Herpolsheimer A, Waimberg J, Burris S. State laws governing syringe services programs and participant syringe possession, 2014-2019. Public Health Rep. 2020;135(1_suppl):128S–37S. doi:10.1177/0033354920921817.
   PubMed Web of Science ®Google Scholar
• Locations SEP. North American syringe exchange network website; 2020. [accessed 2021 Jul 1]. https://www.nasen.org/map/.
   Google Scholar
• Des Jarlais DC, Feelemyer J, LaKosky P, Szymanowski K, Arasteh K. Expansion of syringe service programs in the United States, 2015-2018. Am J Public Health. 2020;110(4):517–9. doi:10.2105/AJPH.2019.305515.
   PubMed Web of Science ®Google Scholar
• Des Jarlais DC, Nugent A, Solberg A, Feelemyer J, Mermin J, Holtzman D. Syringe service programs for persons who inject drugs in urban, suburban, and rural areas - United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64(48):1337–41. doi:10.15585/mmwr.mm6448a3.
   PubMed Web of Science ®Google Scholar
• Canary L, Hariri S, Campbell C, Young R, Whitcomb J, Kaufman H, Vellozzi C. Geographic disparities in access to syringe services programs among young persons with hepatitis C virus infection in the United States. Clin Infect Dis. 2017;65(3):514–7. doi:10.1093/cid/cix333.
   PubMed Web of Science ®Google Scholar
• McGinty EE, Barry CL, Stone EM, Niederdeppe J, Kennedy-Hendricks A, Linden S, Sherman SG. Public support for safe consumption sites and syringe services programs to combat the opioid epidemic. Prev Med. 2018;111:73–7. doi:10.1016/j.ypmed.2018.02.026.
   PubMed Web of Science ®Google Scholar
• Jones CM. Syringe services programs: an examination of legal, policy, and funding barriers in the midst of the evolving opioid crisis in the U.S. Int J Drug Policy. 2019;70:22–32. doi:10.1016/j.drugpo.2019.04.006.
   PubMed Web of Science ®Google Scholar
• Schranz AJ, Barrett J, Hurt CB, Malvestutto C, Miller WC. Challenges facing a rural opioid epidemic: treatment and prevention of HIV and hepatitis C. Curr HIV/AIDS Rep. 2018;15(3):245–54. doi:10.1007/s11904-018-0393-0.
   PubMed Web of Science ®Google Scholar
• Rosenberg ES, Rosenthal EM, Hall EW, Barker L, Hofmeister MG, Sullivan PS, Dietz P, Mermin J, Ryerson AB. Prevalence of hepatitis C virus infection in US states and the District of Columbia, 2013 to 2016. JAMA Netw Open. 2018;1(8):e186371. doi:10.1001/jamanetworkopen.2018.6371.
   PubMed Web of Science ®Google Scholar
• Bates MC, Annie F, Jha A, Kerns F. Increasing incidence of IV-drug use associated endocarditis in southern West Virginia and potential economic impact. Clin Cardiol. 2019;42(4):432–7. doi:10.1002/clc.23162.
   PubMed Web of Science ®Google Scholar
• Gray ME, Rogawski McQuade ET, Scheld WM, Dillingham RA. Rising rates of injection drug use associated infective endocarditis in Virginia with missed opportunities for addiction treatment referral: a retrospective cohort study. BMC Infect Dis. 2018;18(1):532. doi:10.1186/s12879-018-3408-y.
   PubMedGoogle Scholar
• Drug Overdose Deaths in Appalachia. NORC website. Updated n.d. [accessed 2020 Oct 11]. https://overdosemappingtool.norc.org/.
   Google Scholar
• Oconee County, SC. Census Reporter website. Updated 2019. [accessed 2020 Oct 11]. https://censusreporter.org/profiles/05000US45073-oconee-county-sc/.
   Google Scholar
• Appalachian Counties Served by ARC. Appalachian Regional Commission website. Updated n.d. [accessed 2020 Oct 11]. https://www.arc.gov/Appalachian_region/CountiesinAppalachia.asp.
   Google Scholar
• SC DHEC. Drug overdose deaths South Carolina 2019. Columbia (SC): SC DHEC; 2020.
   Google Scholar
• South Carolina Code of Laws. The South Carolina poisons, drugs, and other controlled dangerous substances act, S.C. Code Ann. §.44-53-10. [accessed 2020 Dec 4]. https://www.scstatehouse.gov/code/t44c053.php.
   Google Scholar
• Beachler T, Zeller TA, Heo M, Lanzillotta-Rangeley J, Litwin AH. Community attitudes toward opioid use disorder and medication for opioid use disorder in a rural Appalachian County. J Rural Health. 2021;37(1):29–34. doi:10.1111/jrh.12503.
   PubMed Web of Science ®Google Scholar
• Dew B, Elifson K, Dozier M. Social and environmental factors and their influence on drug use vulnerability and resiliency in rural populations. J Rural Health. 2007;23 Suppl (s1):16–21. doi:10.1111/j.1748-0361.2007.00119.x.
   PubMedGoogle Scholar
• Bachhuber MA, McGinty EE, Kennedy-Hendricks A, Niederdeppe J, Barry CL. Messaging to increase public support for naloxone distribution policies in the United States: results from a randomized survey experiment. PLoS One. 2015;10(7):e0130050. doi:10.1371/journal.pone.0130050.
   PubMed Web of Science ®Google Scholar
• Davis SM, Davidov D, Kristjansson AL, Zullig K, Baus A, Fisher M. Qualitative case study of needle exchange programs in the Central Appalachian region of the United States. PLoS One. 2018;13(10):e0205466. doi:10.1371/journal.pone.0205466.
   PubMed Web of Science ®Google Scholar
• Downing M, Riess TH, Vernon K, Mulia N, Hollinquest M, McKnight C, Jarlais DCD, Edlin BR. What’s community got to do with it? Implementation models of syringe exchange programs. AIDS Educ Prev. 2005;17(1):68–78. doi:10.1521/aeap.17.1.68.58688.
   PubMed Web of Science ®Google Scholar